0QF:FRA
Moderna Inc
180,26 €
arrow_upward
+0,09%(+0,16) 1D
6 қаз., 13:56:43 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
184,78 €
High
184,98 €
Low
180,26 €
Mkt. cap
81,13 млрд
Avg. vol.
1,71 мың
Volume
1,06 мың
52-wk high
184,98 €
52-wk low
19,26 €
No. of employees
5 мың
Open
184,78 €
High
184,98 €
Low
180,26 €
Mkt. cap
81,13 млрд
Avg. vol.
1,71 мың
Volume
1,06 мың
52-wk high
184,98 €
52-wk low
19,26 €
No. of employees
5 мың
News stories
From web sources and news partners
FXLeaders
·
3 минут бұрын
Moderna Stock Holds Near $189 as Nasdaq-100 Entry and Cancer Data Drive Focus
Seeking Alpha
·
1 сағат бұрын
Novavax, Moderna cool as WHO downplays plague-related death in Russia
AD HOC NEWS
·
1 сағат бұрын
Nasdaq adds Moderna to Nasdaq-100 and lifts visibility for Moderna stock
The Daily Free Press
·
8 сағат бұрын
The ‘Edison of Medicine’: Moderna founder visits BU for Q&A event, shares encouragement, life experience
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc